Immatics Stock (NASDAQ: IMTX) stock price, news, charts, stock research, profile.
Open | $11.85 |
Close | - |
Volume / Avg. | 269.94K / 501.57K |
Day Range | 11.52 - 12.32 |
52 Wk Range | 7.15 - 13.77 |
Market Cap | $1.22B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 12.08% |
Days to Cover | 13.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immatics (NASDAQ:IMTX) through any online brokerage.
Other companies in Immatics’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Cogent Biosciences (NASDAQ:COGT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).
There is no analysis for Immatics.
Immatics has a consensus price target of $16.75.
The stock price for Immatics (NASDAQ: IMTX) is $12.255 last updated Today at July 9, 2024 at 3:28 PM EDT.
There are no upcoming dividends for Immatics.
Immatics’s Q2 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for Immatics.
Immatics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.